Compact, single-use, and simple-to-use technology offers surgeons a fast, reliable navigation solution for hip arthroplasty Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company,...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the review of medical technologies guidance from the UK National Institute for Health and Care Excellence (NICE)...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has been named the Preferred Sports Medicine Technology Partner of UFC “ the world's premier mixed martial...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announced they have entered into a Master Cooperative Research and Development Agreement (CRADA) with the U.S. Army...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces full commercial availability of its AETOS Shoulder System in the US, along with 510(k) clearance for its use...
12 February 2024 Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the premiere of its newly acquired CARTIHEAL—Š AGILI-C—Š Cartilage Repair Implant alongside the...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces a new report examining musculoskeletal injury care and reimbursement in Australia that urges health payers and providers to resolve system-wide challenges hindering positive patient pathways from primary settings through to recovery.
New study confirms Smith+Nephew™s REGENETEN Bioinductive Implant reduces full-thickness rotator cuff re-tear rates¹ by 68%
Nov 2 (Reuters) - British medical products maker Smith+Nephew (SN.L) said weight-loss drugs could help previously ineligible overweight patients get approval for joint replacement surgery, playing down concerns about the impact of the new therapies on its business.
Smith+Nephew, the global medical technology company, has announced an agreement with NAVBIT to exclusively distribute the NAVBIT SPRINT disposable navigation device for use in primary hip arthroplasty in Japan. NAVBIT SPRINT delivers a fast and reliable alternative to capital investment improving efficiencies for hospitals.